The Clinicians’ Guide to Managing Immune-Related Adverse Events: An Interactive Algorithm Tool

Using 2 real-world clinical scenarios, this commentary focuses on practical strategies to manage pulmonary and endocrine adverse events associated with checkpoint inhibition in melanoma.

Jeffrey S. Weber, MD, PhD Released: September 26, 2016

This commentary describes 2 cases from my clinic and our experience managing hepatic, neurologic, and hematologic adverse events in patients treated for melanoma with immune checkpoint inhibitors.

Michael Postow, MD Released: October 27, 2016

How do preexisting autoimmune conditions such as ulcerative colitis and rheumatoid arthritis affect management of melanoma with checkpoint inhibitors?

Osama E. Rahma, MD Released: February 8, 2017

In this CME-certified educational module, CCO’s expert faculty members highlight case-based examples to discuss the management of adverse events during checkpoint inhibitor therapy.

Jeffrey S. Weber, MD, PhD
Program Director Michael Postow, MD Osama E. Rahma, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Released: March 3, 2017 Expired: No longer available for credit